KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Campbell'S (CPB) Research & Development (2016 - 2026)

Campbell'S has reported Research & Development over the past 18 years, most recently at $22.0 million for Q1 2026.

  • For Q1 2026, Research & Development fell 12.0% year-over-year to $22.0 million; the TTM value through Feb 2026 reached $95.0 million, down 8.65%, while the annual FY2025 figure was $100.0 million, 1.96% down from the prior year.
  • Research & Development for Q1 2026 was $22.0 million at Campbell'S, down from $24.0 million in the prior quarter.
  • Over five years, Research & Development peaked at $27.0 million in Q2 2024 and troughed at $21.0 million in Q1 2022.
  • A 5-year average of $23.9 million and a median of $24.0 million in 2023 define the central range for Research & Development.
  • Biggest five-year swings in Research & Development: increased 19.05% in 2024 and later dropped 14.81% in 2025.
  • Year by year, Research & Development stood at $21.0 million in 2022, then increased by 14.29% to $24.0 million in 2023, then rose by 8.33% to $26.0 million in 2024, then fell by 7.69% to $24.0 million in 2025, then fell by 8.33% to $22.0 million in 2026.
  • Business Quant data shows Research & Development for CPB at $22.0 million in Q1 2026, $24.0 million in Q4 2025, and $26.0 million in Q3 2025.